Total Payments
$489,217
2023 Payments
$11,677
Companies
11
Transactions
281
Medicare Patients
1,090
Medicare Billing
$237,320
Payment Breakdown by Category
Other$254,471 (52.0%)
Consulting$111,386 (22.8%)
Travel$98,603 (20.2%)
Research$19,625 (4.0%)
Food & Beverage$5,132 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $252,575 | 30 | 51.6% |
| Consulting Fee | $111,386 | 54 | 22.8% |
| Travel and Lodging | $98,603 | 96 | 20.2% |
| Unspecified | $19,625 | 5 | 4.0% |
| Food and Beverage | $5,132 | 94 | 1.0% |
| Grant | $1,896 | 2 | 0.4% |
Payments by Type
General
$469,592
276 transactions
Research
$19,625
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $467,444 | 264 | $0 (2023) |
| Calyxo, Inc. | $19,741 | 6 | $0 (2023) |
| UROGEN PHARMA, INC. | $1,540 | 2 | $0 (2021) |
| Dornier MedTech America, Inc | $335.10 | 1 | $0 (2023) |
| Olympus America Inc. | $29.01 | 2 | $0 (2022) |
| Tolmar, Inc. | $27.88 | 1 | $0 (2023) |
| 180 Medical, Inc. | $26.66 | 1 | $0 (2021) |
| Medtronic, Inc. | $23.93 | 1 | $0 (2023) |
| Ambu Inc. | $21.12 | 1 | $0 (2020) |
| Palette Life Sciences, Inc. | $15.78 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $11,677 | 8 | Boston Scientific Corporation ($7,425) |
| 2022 | $14,061 | 11 | Calyxo, Inc. ($12,875) |
| 2021 | $12,037 | 14 | BOSTON SCIENTIFIC CORPORATION ($7,470) |
| 2020 | $14,671 | 9 | Boston Scientific Corporation ($14,650) |
| 2019 | $66,413 | 59 | BOSTON SCIENTIFIC CORPORATION ($66,413) |
| 2018 | $183,281 | 97 | Boston Scientific Corporation ($183,281) |
| 2017 | $187,076 | 83 | BOSTON SCIENTIFIC CORPORATION ($187,076) |
All Payment Transactions
281 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2023 | Dornier MedTech America, Inc | Dornier MedTech (Device) | Food and Beverage | In-kind items and services | $335.10 | General |
| Category: Not Applicable | ||||||
| 07/26/2023 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | — | Cash or cash equivalent | $3,750.00 | Research |
| Study: ASPIRE • Category: Orthodontic Dentistry | ||||||
| 04/30/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: General - Therapies_URO | ||||||
| 04/27/2023 | Tolmar, Inc. | JATENZO (Drug), ELIGARD | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: Endogenous Testosterone Replacement Therapy | ||||||
| 04/21/2023 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $7,000.00 | General |
| Category: Clinical Trial Product_URO | ||||||
| 04/21/2023 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| Category: Clinical Trial Product_URO | ||||||
| 03/28/2023 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $115.68 | General |
| Category: Orthodontic Dentistry | ||||||
| 01/09/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 12/16/2022 | Boston Scientific Corporation | General - Kidney Stone Disease (Device) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: General - Kidney Stone Disease_URO | ||||||
| 10/14/2022 | Calyxo, Inc. | CVAC (Device) | — | Cash or cash equivalent | $2,375.00 | Research |
| Study: ASPIRE • Category: Urology | ||||||
| 10/14/2022 | Calyxo, Inc. | CVAC (Device) | — | Cash or cash equivalent | $2,125.00 | Research |
| Study: ASPIRE • Category: Urology | ||||||
| 10/03/2022 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: LithoVue_URO | ||||||
| 10/02/2022 | Boston Scientific Corporation | General - Kidney Stone Disease (Device) | Food and Beverage | In-kind items and services | $116.62 | General |
| Category: General - Kidney Stone Disease_URO | ||||||
| 09/28/2022 | Coloplast Corp | Porges Coloplast (Device) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Endourology | ||||||
| 07/12/2022 | Olympus America Inc. | — | Food and Beverage | In-kind items and services | $13.31 | General |
| 06/01/2022 | Calyxo, Inc. | CVAC (Device) | — | Cash or cash equivalent | $8,375.00 | Research |
| Study: ASPIRE • Category: Urology | ||||||
| 05/19/2022 | Palette Life Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.78 | General |
| 02/03/2022 | Boston Scientific Corporation | General - Kidney Stone Disease (Device) | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| Category: General - Kidney Stone Disease_URO | ||||||
| 01/31/2022 | Olympus America Inc. | — | Food and Beverage | In-kind items and services | $15.70 | General |
| 12/15/2021 | BOSTON SCIENTIFIC CORPORATION | LITHOVUE (Device) | Food and Beverage | In-kind items and services | $97.26 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/11/2021 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Consulting Fee | Cash or cash equivalent | $770.00 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/27/2021 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Consulting Fee | Cash or cash equivalent | $770.00 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/12/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL KIDNEY STONE DISEASE (Device) | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/31/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL KIDNEY STONE DISEASE (Device) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/27/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL KIDNEY STONE DISEASE (Device) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: PAIN MANAGEMENT | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ASPIRE | Calyxo, Inc. | $19,625 | 5 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 213 | 227 | $206,880 | $34,030 |
| 2022 | 8 | 237 | 260 | $293,034 | $49,733 |
| 2021 | 9 | 337 | 370 | $490,679 | $83,012 |
| 2020 | 10 | 303 | 324 | $419,855 | $70,545 |
Total Patients
1,090
Total Services
1,181
Medicare Billing
$237,320
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 50081 | Complex surgical treatment of kidney stone with imaging guidance | Facility | 2023 | 12 | 13 | $69,511 | $12,452 | 17.9% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 20 | 22 | $45,716 | $7,262 | 15.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 77 | $14,483 | $5,326 | 36.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 44 | 44 | $13,948 | $3,621 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 24 | $7,134 | $2,321 | 32.5% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 15 | 17 | $15,552 | $1,226 | 7.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 17 | 17 | $4,301 | $1,039 | 24.2% |
| 50432 | Placement of tube of kidney using imaging guidance with review by radiologist | Facility | 2023 | 13 | 13 | $36,235 | $784.05 | 2.2% |
| 50081 | Removal or crushing kidney stone or insertion of kidney stent using an endoscope, more than 2.0 cm | Facility | 2022 | 17 | 19 | $101,593 | $20,868 | 20.5% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2022 | 27 | 29 | $68,574 | $10,766 | 15.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 80 | 88 | $13,640 | $6,493 | 47.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 55 | 55 | $17,435 | $4,805 | 27.6% |
| 50961 | Removal of foreign body or stone in kidney or ureter using an endoscope inserted through an already created opening in ureter | Facility | 2022 | 15 | 17 | $22,338 | $2,301 | 10.3% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 14 | 21 | $19,872 | $1,692 | 8.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 13 | $3,250 | $1,421 | 43.7% |
| 50432 | Placement of tube of kidney using imaging guidance with review by radiologist | Facility | 2022 | 16 | 18 | $46,332 | $1,388 | 3.0% |
| 50081 | Removal or crushing kidney stone (over 2 centimeters) or insert kidney stent using an endoscope, accessed through the skin | Facility | 2021 | 32 | 35 | $187,145 | $38,700 | 20.7% |
| 52356 | Crushing of stone in urinary duct (ureter) with stent using an endoscope | Facility | 2021 | 33 | 37 | $81,042 | $13,398 | 16.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 71 | 83 | $12,865 | $6,175 | 48.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 62 | 62 | $19,654 | $5,738 | 29.2% |
| 52344 | Endoscope of the bladder, urethra and ureter to treat a stricture of ureter | Facility | 2021 | 17 | 19 | $26,999 | $5,353 | 19.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 42 | 44 | $11,000 | $4,696 | 42.7% |
| 50961 | Removal of foreign body or stone from kidney or urinary duct (ureter) using an endoscopy which is inserted through an already created urinary duct (ureter) opening | Facility | 2021 | 27 | 30 | $39,420 | $4,084 | 10.4% |
| 50432 | Placement of catheter of kidney, accessed through the skin using imaging guidance with radiological supervision and interpretation | Facility | 2021 | 32 | 35 | $90,090 | $2,940 | 3.3% |
| 52332 | Insertion of stent in urinary duct (ureter) using an endoscope | Facility | 2021 | 21 | 25 | $22,464 | $1,927 | 8.6% |
About Dr. Brian Matlaga, M.D
Dr. Brian Matlaga, M.D is a Urology healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427009539.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Matlaga, M.D has received a total of $489,217 in payments from pharmaceutical and medical device companies, with $11,677 received in 2023. These payments were reported across 281 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($252,575).
As a Medicare-enrolled provider, Matlaga has provided services to 1,090 Medicare beneficiaries, totaling 1,181 services with total Medicare billing of $237,320. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Baltimore, MD
- Active Since 05/13/2006
- Last Updated 02/12/2013
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1427009539
Products in Payments
- LITHOVUE (Device) $142,426
- GENERAL - KIDNEY STONE DISEASE (Device) $94,255
- GENERAL KIDNEY STONE DISEASE (Device) $64,064
- GENERAL - THERAPIES (Device) $49,290
- THERAPIES (Device) $42,766
- GENERAL KIDNEY STONE DISEASE (Device) $28,021
- GENERAL THERAPIES (Device) $15,932
- CVAC (Device) $15,875
- OTHER- BSC PRODUCT NOT LISTED (Device) $9,979
- GENERAL KIDNEY STONE DISEASE (Device) $7,000
- CVAC ASPIRATION SYSTEM (Device) $3,866
- UPSYLON (Device) $1,800
- JELMYTO (Drug) $1,540
- CLINICAL TRIAL PRODUCT (Device) $1,200
- General - Kidney Stone Disease (Device) $1,117
- LithoVue (Device) $782.69
- GENERAL THERAPIES (Device) $462.47
- SENSOR (Device) $450.00
- Dornier MedTech (Device) $335.10
- Sensor (Device) $256.35
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Baltimore
Dr. George Mamo, M.d, M.D
Urology — Payments: $1.4M
Urology $1.4M
Benjamin Lowentritt, M.d, M.D
Urology — Payments: $608,373
Urology $608,373
Ronald Tutrone, M.d, M.D
Urology — Payments: $148,343
Urology $148,343
Arthur Burnett, M.d, M.D
Urology — Payments: $135,418
Urology $135,418
Amin Herati, M.d, M.D
Urology — Payments: $131,870
Urology $131,870
Dr. Aaron Weinberg
Urology — Payments: $85,909
Urology $85,909